Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity

BACKGROUND: The donepezil-memantine combination is a US Food and Drug Administration (FDA)–approved medication to treat Alzheimer’s disease (AD). Galantamine is superior to donepezil because it is a positive allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (α7nAChR). Although gal...

Descripción completa

Detalles Bibliográficos
Autores principales: Koola, Maju Mathew, Nikiforuk, Agnieszka, Pillai, Anilkumar, Parsaik, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457262/
https://www.ncbi.nlm.nih.gov/pubmed/30984874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457262/
https://www.ncbi.nlm.nih.gov/pubmed/30984874

Ejemplares similares